Generic Cytoxan is used for treating certain types of the following cancers: lymphoma, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian cancer, eye cancer and breast cancer. It is usually used in combination with other medicines. It may also be used to treat certain kidney problems (nephrotic syndrome) in children. More info »
MAN, i went thru those 30 tablets like nothing, WHEW, they were great. I
could really use the other 60. I have to say your pills are one of the
better generic viagras I have expereienced so far on my comeback trail. do
you offer the the much quicker and more flavorful melt tabs. if you do, I
would like to possibly upgrade on the remaining 60 (if they have not been
shipped yet) It all depends on the price difference, just let me know.
maybe we can work something out.
- glenn
Cyclophosphamide drug makes the bone marrow more tumor-friendly - News-Medical.net
Cyclophosphamide drug makes the bone marrow more tumor-friendlyNews-Medical.
U-M researches say common chemotherapy drug enables tumors in bone marrow - AnnArbor.com
U-M researches say common chemotherapy drug enables tumors in bone marrowAnnArbor.
Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab? - Cancer Network
Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?Cancer NetworkIn their review article in this issue of ONCOLOGY, Nastoupil, Rose, and Flowers discuss the progress from the older chemotherapy regimen, CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), to immuno-chemotherapy.
Successful Treatment of Antineutrophil Cytoplasmic Antibody–Associated ... - Annals of Internal Medicine
Successful Treatment of Antineutrophil Cytoplasmic Antibody–Associated .
Is There a Best Adjuvant Chemotherapy Regimen for Breast Cancer? - OncLive
OncLiveIs There a Best Adjuvant Chemotherapy Regimen for Breast Cancer?OncLiveCytotoxic therapy consisting of cyclophosphamide– methotrexate–5-fluorouracil (CMF)-based regimens showed a 24% reduction in breast cancer recurrence and 14% reduction in death, compared with placebo.